The following schedule is from the 2021 program. Information on the 2022 course will be posted soon.
Thurs. Nov. 4
| 7:45 AM | 8:00 AM | Introduction and Welcome: A Collective Call to Action |
| COMPREHENSIVE APPROACHES TO OBESITY: BLUNTING ITS IMPACT | ||
| 8:00 AM | 8:26 AM | Exercise: Quick and Effective In-Office Risk Assessment and Personalized “Prescription” Strategies* Edward M. Phillips, MD |
| 8:26 AM | 8:58 AM | State-of-the-Art Nutritional Approaches to Weight Management: One Size Does Not Fit All* Jody Dushay, MD, MMSc |
| 8:58 AM | 9:10 AM | Question and Answer Session |
| 9:10 AM | 9:25 AM | Break and Guided Meditation✻ |
| 9:25 AM | 9:55 AM | Impacting Diabetes Outcomes with New Techniques for Motivation Interviewing: Here’s How*† Frank J. Domino, MD |
| 9:55 AM | 10:40 AM | Non-Alcoholic Steatohepatitis: Assessing Severity and Optimizing Management Sanjiv Chopra, MD, MACP, FRCP (London) |
| 10:40 AM | 10:50 AM | Question and Answer Session |
| 10:50 AM | 11:00 AM | Break |
| 11:00 AM | 11:43 AM | Pharmacologic Management of Obesity: When. What. How.*† Osama Hamdy, MD, PhD, FACE |
| 11:43 AM | 12:05 PM | Surgical Treatment of Obesity: Techniques, Outcomes, and a Patient’s Perspective* Daniel B. Jones, MD, MS, FACS Maria Semnack, RN, BSN |
| 12:05 PM | 12:20 PM | Question and Answer Session |
| 12:20 PM | 1:10 PM | Lunch Break |
| SPECIAL SYMPOSIUM: CARDIOVASCULAR DISEASE AND DIABETES | ||
| 1:10 PM | 1:52 PM | Optimal Management of Hypertension in People with Diabetes† Melanie P. Hoenig, MD |
| 1:52 PM | 2:37 PM | Optimal Management of Dyslipidemia in People with Diabetes† Om P. Ganda, MBBS, MD |
| 2:37 PM | 2:50 PM | Question and Answer Session |
| 2:50 PM | 3:05 PM | Break & Rejuvenation Exercises✻ |
| 3:05 PM | 3:34 PM | Common Cardiovascular Tests and Their Optimal Interpretation Michael C. Gavin, MD, MPH, FACC |
| 3:34 PM | 4:15 PM | Diabetes and Heart Failure: Update on Management† Arthur Reshad Garan, MD, MS, FACC |
| 4:15 PM | 4:25 PM | Break |
| 4:25 PM | 4:54 PM | Management of Acute Coronary Syndromes and Chronic Cardiovascular Disease in Patients with Diabetes† Duane S. Pinto, MD, MPH |
| 4:54 PM | 5:15 PM | Panel Discussion: Cardiovascular Care in People with Diabetes Duane S. Pinto, MD, MPH Arthur Reshad Garan, MD, MS, FACC Michael C. Gavin, MD, MPH, FACC |
Fri. Nov. 5
| UPDATES ON THE MEDICAL MANAGEMENT OF DIABETES | ||
| 7:30 AM | 8:25 AM | Beyond Metformin: Navigating and Applying the New Guidelines and Reducing Cardiovascular Risk*† Martin J. Abrahamson, MD, FACP |
| 8:25 AM | 8:30 AM | Question and Answer Session |
| 8:30 AM | 9:25 AM | Newer Insulins and How to Use Them: A Comprehensive Primer† Richard S. Beaser, MD |
| 9:25 AM | 9:30 AM | Question and Answer Session |
| 9:30 AM | 9:45 AM | Break and Guided Meditation✻ |
| 9:45 AM | 10:24 AM | The Use of Devices for Diabetes Management*† Anne Peters, MD |
| 10:24 AM | 10:30 AM | Question and Answer Session |
| 10:30 AM | 10:35 AM | Break |
| SPECIAL WORKSHOP: CHALLENGING CASES IN GLYCEMIC CONTROL | ||
| 10:35 AM | 11:50 AM | Challenges in Optimizing Glycemic Control: An Interactive Session† Martin J. Abrahamson, MD, FACP Gillian Arathuzik, RD, LDN, CDCES Richard S. Beaser, MD Mary Paschal, RN, MS, CDCES Alissa R. Segal, PharmD, CDCES, CDTC, FCCP |
| 11:50 AM | 12:15 PM | Q&A: Medical Management of Diabetes† |
| 12:15 PM | 1:05 PM | Lunch Break |
| 1:05 PM | 1:32 PM | KEYNOTE: Microbiome (the Second Human Genome): What Shapes It and How It Shapes Us Sanjiv Chopra, MD, MACP, FRCP (London) |
| SPECIAL SITUATIONS | ||
| 1:32 PM | 2:10 PM | The Challenges of Inpatient Diabetes Management and Transition to Outpatient Care*† Lyle D. Mitzner, MD |
| 2:10 PM | 2:15 PM | Question and Answer Session |
| 2:15 PM | 2:30 PM | Break & Rejuvenation Exercises✻ |
| 2:30 PM | 3:09 PM | Managing Diabetes in the Elderly – Individualizing Care*† Medha N. Munshi, MD |
| 3:09 PM | 3:58 PM | Care for Pregnant Women and Women Planning to Become Pregnant: Screening, Risk Mitigation, Treatment, Patient Education*† Florence M. Brown, MD |
| 3:58 PM | 4:10 PM | Question and Answer Session |
| 4:10 PM | 4:20 PM | Break |
| 4:20 PM | 5:06 PM | Disparities in Diabetes Care* Samar Hafida, MD |
| 5:06 PM | 5:15 PM | Question-and-Answer Session |
Sat. Nov. 6
| 7:30 AM | 8:00 AM | How to (Recognize and) Factor the Emotional and Psychological Needs of Patients with Diabetes into Your Clinical Care* Aaron M. Price, LICSW |
| 8:00 AM | 8:05 AM | Question-and-Answer Session |
| SYMPOSIUM TO CELEBRATE THE 100th ANNIVERSARY OF THE DISCOVERY OF INSULIN | ||
| 8:05 AM | 8:29 AM | Insulin Therapy for Diabetes: From Discovery to Today*† Bernard Zinman, OC, MDCM, FRCPC, FACP |
| 8:29 AM | 9:06 AM | The Artificial Pancreas: Ready for Prime Time? Steven J. Russell, MD, PhD |
| 9:06 AM | 9:20 AM | Break & Rejuvenation Exercises✻ |
| 9:20 AM | 10:04 AM | Future Therapies for Diabetes*† Alan Moses, MD |
| 10:04 AM | 10:20 AM | Panel Discussion: Discovery of Insulin Bernard Zinman, OC, MDCM, FRCPC, FACP Steven J. Russell, MD, PhD Alan Moses, MD |
| 10:20 AM | 10:30 AM | Break |
| MICROVASCULAR DISEASE AND DIABETES | ||
| 10:30 AM | 11:04 AM | Treating Retinopathy: Optimizing the Impact of Recent Advances Deborah K. Schlossman, MD |
| 11:04 AM | 11:52 AM | Treatment of Renal Disease: Guidance to Blunt the Impact, Slow the Progression† Robert C. Stanton, MD |
| 11:52 AM | 12:22 PM | Evaluating and Treating Neuropathies of Diabetes: 2021 Updates Patricia E. Greenstein, MD |
| 12:22 PM | 12:40 PM | Question and Answer Session |
| 12:40 PM | 1:30 PM | Lunch Break |
| THE DIABETIC FOOT | ||
| 1:30 PM | 2:08 PM | The Foot: Preventing Damage and Treatment Options* John M. Giurini, DPM |
| 2:08 PM | 2:32 PM | Peripheral Vascular Disease: Recent Advances in Diagnosis and Management† David R. Campbell, MD, FRCS, FACS |
| 2:32 PM | 2:45 PM | Question and Answer Session |
| 2:45 PM | 2:50 PM | Break |
| 2:50 PM | 3:24 PM | KEYNOTE: Stem Cells David T. Scadden, MD |
| 3:24 PM | 3:35 PM | Question and Answer Session |
| SPECIAL SESSION | ||
| 3:35 PM | 3:50 PM | Indispensable Tips for Incorporating Updates into Clinical Practice and Closing Remarks |
Note: Program changes/substitutions may be made without notice.
This agenda was updated on 10/18/2021.
*Qualifies for Risk Management Credit
†Qualifies for Pharmacology Credit
✻Optional Wellness Activity
REGISTER EARLY AND SAVE!
*This Course Will Be Live-Streamed*
Special pricing is in effect for this program.This course will be live-streamed and includes real-time audience-response questions, live demonstrations and interactive Q&A sessions allowing you to pose specific questions to our expert faculty via online chat. All presentations and course materials will be available immediately to watch and review at your convenience.
All live-stream sessions are eligible for AMA PRA Category 1 Credits™ and ABIM MOC points, as well as other relevant CME credits.